Clinical Trials Browser

Not yet recruiting × sacituzumab govitecan × CNS × Clear all

NCT06462079 2024-06-17

Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain Metastases

Phase 2 Not yet recruiting

Brain Neoplasms, Breast Neoplasms